Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

None (ATRC)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 4
  • 1 comments

(28% Negative) AtriCure, Inc. (ATRC) Reports 121% Loss Increase for 2025-09-30

Comment Full text

None (CAH)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 2
  • 1 comments

(56% Neutral) Cardinal Health, Inc. (CAH) Reports Profit for 2025-09-30

Comment Full text

None (ARDX)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 3
  • 1 comments

(75% Positive) ARDELYX, INC. (ARDX) Reports Net Loss for 2025-09-30

Comment Full text

None (ALNY)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 4
  • 1 comments

(4% Negative) ALNYLAM PHARMACEUTICALS, INC. (ALNY) Reports 253% Loss Increase for 2025-09-30

Comment Full text

None (PHAT)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 5
  • 1 comments

(13% Negative) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Net Loss for 2025-09-30

Comment Full text

None (INDV)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 5
  • 1 comments

(70% Positive) Indivior PLC (INDV) Reports 2000% Profit Growth for 2025-09-30

Comment Full text

None (NUVL)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 5
  • 1 comments

(75% Positive) NUVALENT, INC. (NUVL) Reports 39% Loss Reduction for 2025-09-30

Comment Full text

None (APLS)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 4
  • 1 comments

(4% Negative) APELLIS PHARMACEUTICALS, INC. (APLS) Reports 299% Loss Increase for 2025-09-30

Comment Full text

None (NVNO)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 1
  • 1 comments

(52% Neutral) enVVeno Medical Corporation (NVNO) Reports Net Loss for 2025-09-30

Comment Full text

None (PSTV)

  • SEC News
  • Oct. 30, 2025, 00:00 UTC
  • 1
  • 1 comments

(56% Neutral) PLUS THERAPEUTICS, INC. (PSTV) Reports 46% Loss Reduction for 2025-09-30

Comment Full text
  • Previous
  • 45
  • 46
  • 47
  • 48
  • 49
  • Next

Search

News categories

  • Technical Exchange News(10321)
  • Event(1442)
  • SEC News(175251)
  • FDA Approval(9644)
  • Company Report(721)
  • Business News(117555)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin